bf/NASDAQ:AYTU_icon.png

NASDAQ:AYTU

Aytu BioPharma, Inc.

  • Stock

USD

Last Close

2.14

06/11 21:00

Market Cap

16.90M

Beta: −0.41

Volume Today

70.27K

Avg: 68.94K

PE Ratio

−0.52

PFCF: 3.71

OverviewFinancialsAPI

    Description

    Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patie...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -4000-3000-2000-10002018-02-082020-02-132021-09-272023-09-272024-11-13

    Revenue (Estimate*)

    20M40M60M80M2018-02-082020-02-132021-09-272023-09-272024-11-13

    *Estimate based on analyst consensus